ScripAbbVie is expanding its presence in the emerging field of trispecific antibodies for multiple myeloma with a second licensing deal, this time with IGI Therapeutics for ISB 2001, a CD38xBCMAxCD3-direct
In VivoRiding high on the wave of its dual GIP/GLP-1 agonist, tirzepatide, Eli Lilly awarded its CEO the highest total remuneration package of the top 12 big pharma companies in 2024. David Ricks’s total com
Pink SheetThe budget reconciliation legislation making President Trump’s 2017 tax cuts permanent and sharply reducing federal spending in Medicaid and the Affordable Care Act insurance market provides manufactu
ScripSummer is the time for sequels at the multiplex, and the biopharmaceutical sector offered a remake of its own as many of the datapoints for merger-and-acquisition activity during the second quarter ca